Publications by authors named "Claudio Bravo"

Claim this Profile
H
Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist device.
Aris Karatasakis, Edwin Grajeda Silvestri, Gatha G Nair, Benjamin Zuniga, Song Li, Claudio A Bravo

ESC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous Assessment and Intervention of Outflow Graft Stenosis in Left Ventricular Assist Device Patients-A Cohort Study.
Claudio A Bravo, Fanette Chassagne, Alberto Aliseda, Jennifer A Beckman, Song Li

ASAIO J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Société de Biomécanique Young Investigator Award: In silico study of the effects of Left Ventricular Assist Device inflow cannula design and pump unsteady flow on left ventricular hemodynamics.
Fanette Chassagne, Clément Léger, Angela Straccia, Claudio A Bravo, Jennifer A Beckman

J Biomech· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension.
Hongyang Pi, Lu Xia, Olivier Boucherat, Karthik Suresh, Anna R Hemnes, Claudio A Bravo

Circ Heart Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the 2018 Allocation System Change on Patients Bridged With Durable Left Ventricular Assist Device: An Updated UNOS Registry Analysis.
Lorenzo Braghieri, Antonio Olivas-Martinez, Edwin Grajeda Silvestri, Aris Karatasakis, Song Li, Claudio Bravo

ASAIO J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of HIV and HCV Infection With Carotid Artery Plaque Echomorphology in the MACS/WIHS Combined Cohort Study.
Claudio A Bravo, Jee-Young Moon, Krista Davy, Robert C Kaplan, Kathryn Anastos

Stroke· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explainable Machine Learning Analysis of Right Heart Failure After Left Ventricular Assist Device Implantation.
Arjun Bahl, Binish Qureshi, Kevin Zhang, Claudio Bravo, Claudius Mahr

ASAIO J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices.
Ioannis Dimarakis, Paul Callan, Maziar Khorsandi, Jay D Pal, Claudio A Bravo

Front Cardiovasc Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right heart failure after left ventricular assist device: From mechanisms to treatments.
Claudio A Bravo, Andrew G Navarro, Karanpreet K Dhaliwal, Maziar Khorsandi, Jeffrey E Keenan

Front Cardiovasc Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropogenic influence on surface changes at the Olivares glaciers; Central Chile.
Martina Barandun, Claudio Bravo, Bernard Grobety, Theo Jenk, Ling Fang

Sci Total Environ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support.
Cecilia Berardi, Claudio A Bravo, Song Li, Maziar Khorsandi, Jeffrey E Keenan

J Clin Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death.
Claudio A Bravo, Justin A Fried, Joshua Z Willey, Azka Javaid, Giulio M Mondellini

J Card Fail· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected increases in surface melt and ice loss for the Northern and Southern Patagonian Icefields.
Claudio Bravo, Deniz Bozkurt, Andrew N Ross, Duncan J Quincey

Sci Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Assessment of Online Health Information for Coronary Revascularization.
Irbaz Hameed, N U Farrukh Hameed, Christian T Oakley, Ivancarmine Gambardella, Claudio Bravo

JAMA Intern Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure.
Takayuki Yamada, Hiroki Ueyama, Nitin Chopra, Takahiro Yamaji, Kengo Azushima, Claudio A Bravo

Kidney Int Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study.
Claudio A Bravo, Simin Hua, Amy Deik, Jason Lazar, David B Hanna

J Am Heart Assoc· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis.
Wilman Olmedo, Pedro A Villablanca, Cristina Sanina, Jonathan Walker, Michael Weinreich, Claudio A Bravo

Vascular· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock.
Saul A Rios, Claudio A Bravo, Michael Weinreich, Wilman Olmedo, Pedro Villablanca

Am J Cardiol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion.
Jie Zhang, Daniel Levy, Marko Oydanich, Claudio A Bravo, Seonghun Yoon

J Mol Cell Cardiol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
Claudio A Bravo, Sameer A Hirji, Deepak L Bhatt, Christian Gluud, David P Faxon

Heart· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-antiplatelet Therapy Guidelines and Implications for Perioperative Management.
Kristin Stawiarski, Rachna Kataria, Claudio A Bravo, Pedro Villablanca, Divyanshu Mohananey

J Cardiothorac Vasc Anesth· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
Claudio A Bravo, Sameer A Hirji, Deepak L Bhatt, Rachna Kataria, David P Faxon

Cochrane Database Syst Rev· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
Rachna Kataria, Sushmitha Fernandes, Jasmin Lebastchi, Claudio A Bravo, Kanaga N Sena

Conn Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor on "Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?".
Claudio A Bravo, Dorothy E Vatner, Stephen F Vatner

J Pharmacol Exp Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.
Claudio A Bravo, Dorothy E Vatner, Ronald Pachon, Jie Zhang, Stephen F Vatner

J Pharmacol Exp Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis